Search

A recent study from Hanyang University in Seoul, South Korea, explored the use of the Fibrosis-4 (FIB-4) index as a screening tool for liver fibrosis in patients under 65 years of age with type 2 diabetes mellitus (T2DM). The research found that while the diagnostic performance of FIB-4 was suboptimal in T2DM patients, it still holds value as a screening tool in this specific age group. The study compared the diagnostic performance of FIB-4 in T2DM and non-T2DM patients and concluded that its limited use in individuals under 65 with T2DM could be beneficial. [Extracted from the article]